Drugs / MVA62B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01378156 | Jun 2010 → May 2014 | HIV infectious disease | GeoVax, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA62B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01378156 ↗ |
| Modality | Vaccine | “MVA boost vaccine” NCT01378156 ↗ |